focus -WSS

focus

author：fashion 2025-10-01 21:47:44 - browse：53732

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： The high cost of giving birth even with insurance
Next article： Francis Collins on trust in science and how Covid communications failed

Wikipedia

WSS

Research misconduct: Proposed new rules face resistance

MassMutual is introducing free genetic testing for members

eGenesis tests gene

Dogs on Prozac: What pet anti

Cue Health's Covid

Health care needs a new profession: neuroimaging counseling

focus

focus

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Exact Sciences stock tumbles despite strong cancer detection sales

Medical records are filled with copy

Francis Collins on trust in science and how Covid communications failed

Novavax promises a turnaround & Lilly roils the obesity market

Q&A: Jennifer Adair on making gene therapy available globally

Heart attack and stroke risk calculators need revising

eGenesis tests gene

The cancer drug shortage isn’t new — and neither are the solutions

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

focus

H5N1 bird flu virus started spreading in cows in Texas in December

Cue Health's Covid

Dogs on Prozac: What pet anti

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Prior authorization will have to move faster under new Biden rule

NIH director takes cautious approach to Biden drug pricing priority

hotspot

focus

Wikipedia

focus